YETI Holdings
YETI
Lantheus
LNTH
DexCom
DXCM
Hutchmed (China)
HCM
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.3021
- -0.0119-3.79%
Trading Jan 3 10:27 ET
56.46MMarket Cap0.00P/E (TTM)
0.3118High0.2911Low21.82MVolume0.3100Open0.3140Pre Close6.54MTurnover11.67%Turnover Ratio0.00P/E (Static)186.89MShares12.480052wk High0.76P/B56.46MFloat Cap0.118052wk Low--Dividend TTM186.89MShs Float263679868.1600Historical High--Div YieldTTM6.59%Amplitude0.1180Historical Low0.2990Avg Price1Lot Size
Tonix Pharmaceuticals Key Stats
EPS
According to the latest financial report of Tonix Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.23. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Tonix Pharmaceuticals's free cash flow? The latest report shows it as -18.81M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Tonix Pharmaceuticals shows that the company's current ratio is 3.33, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Tonix Pharmaceuticals, the quick ratio is 2.52, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Tonix Pharmaceuticals? The latest ROE figure is -24.44%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Tonix Pharmaceuticals, the total asset return on investment (ROA) is -17.20%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Tonix Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at 44.90%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Tonix Pharmaceuticals, the net profit margin is -503.65%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
